Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05230810 |
|---|---|
| Brief Title: | Clinical Trial of Alpelisb and Tucatinib in Patients With PIK3CA-Mutant HER2+ Metastatic Breast Cancer. |
| First Submitted : | December 27, 2021 |
| First Submitted that Met QC Criteria : | January 28, 2022 |
| First Posted : | February 9, 2022 |
| Last Update Submitted that Met QC Criteria : | December 29, 2022 |
| Last Update Posted : | January 3, 2023 |